The change comes as studies into how psychoactive drugs can impact mental illness are also underway in New Zealand. "They should be introduced into clinical practice as part of a rigorously controlled clinical trial or at the very least a clinical registry. Researchers from the University of Otago, the University of Auckland and independent provider Mana Health are currently investigating whether MDMA can help cancer patients. The new psychedelic-assisted therapy trial announced in June aims at finding a way to help terminal cancer patients struggling with depressive thoughts and emotions. Like Australia, the clinical trial mixes MDMA with psychotherapy (talk therapy) in treating depression and anxiety experienced by patients.
